Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
12 Nov 2026PfizerUnited StatesA Study to Learn About the Study Medicine Called Prifetrastat in People With Renal ImpairmentPhase 1Not Yet Recruiting12 Nov 2026Primus PharmaceuticalsUnited StatesEffect of Metaxalone 640 mg (M640) on Driving, Cognition, and EEG Dynamics Compared to Tizanidine 8 mg in AdultsPhase 4Not Yet Recruiting12 Nov 2026Revision SkincareUnited StatesA Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark SpotsNot applicableCompleted12 Nov 2026SWIMS America Corp.United StatesCombined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic PainNot applicableRecruiting10 Nov 2026Beijing Inno Medicine Co., Ltd.United States, ChinaA Phase I Clinical Study of YN003 in the Treatment of GliomaPhase 1Recruiting10 Nov 2026Corza Medical GmbHUnited StatesEffectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult InpatientsRecruiting10 Nov 2026Eli Lilly and CompanyUnited States, Bulgaria, HungaryA Study of Brenipatide in Participants With Major Depressive DisorderPhase 2Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited StatesA Study of LY3981314 in Participants With Autoimmune HepatitisPhase 1Not Yet Recruiting10 Nov 2026Eli Lilly and CompanyUnited States, France, JapanA Study of LY4336619 in Adult Participants With Advanced Solid TumorsPhase 1Not Yet Recruiting10 Nov 2026Kanglin Biotechnology (Hangzhou) Co., Ltd.United StatesA Phase 1/2a Clinical Study of KL002 in Treatment of Parkinson's DiseasePhase 1, Phase 2Not Yet Recruiting10 Nov 2026MedicureUnited States, AustraliaContinuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyPhase 3Recruiting10 Nov 2026Neuralink CorpUnited StatesAn Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for Neural Control of External Devices in Spinal Cord Injury, Amyotrophic Lateral Sclerosis, and Chronic Ischemic StrokeNot applicableRecruiting10 Nov 2026Peach PerfectUnited StatesA Clinical Trial to Evaluate the Effects of a Supplement on Gut HealthNot applicableRecruiting10 Nov 2026Reselute, Inc.United StatesLocal Antibiotic Delivery From an Intramedullary Nail After Surgical Treatment of Tibial Fractures at High Risk of InfectionNot applicableNot Yet Recruiting10 Nov 2026SATO Pharmaceutical Co., Ltd.United StatesSafety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual OnychomycosisPhase 2Not Yet Recruiting9 Nov 2026AbbVieUnited StatesA Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult ParticipantsPhase 1Recruiting9 Nov 2026Boehringer IngelheimUnited States, Belgium, FinlandA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentPhase 2Not Yet Recruiting9 Nov 2026Boehringer IngelheimUnited States, Australia, JapanA Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D MutationPhase 1Not Yet Recruiting9 Nov 2026CB ConsultingUnited StatesRetrospective Evaluation of Visual Outcomes, Safety and Enhancement Rates Following Wavefront-Guided LASIK Using a 10 MHz Elita Femtosecond LaserRecruiting9 Nov 2026FixNip LtdUnited StatesPREFIX FEASIBILITY Study - PRojection & Safety Evaluation of the FIXNip Nipple Reconstruction ImplantNot applicableRecruiting9 Nov 2026KaileraUnited StatesA Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living With Obesity or OverweightPhase 1Not Yet Recruiting9 Nov 2026PfizerUnited StatesA Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without InhibitorsPhase 3Recruiting9 Nov 2026Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and CompanyUnited StatesA Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney FunctionPhase 1Not Yet Recruiting6 Nov 2026Eli Lilly and CompanyUnited States, Hungary, ItalyA Study of Bimagrumab in Participants With HFpEFPhase 2Not Yet Recruiting6 Nov 2026Meta Platforms Technologies LLCUnited StatesSpeech Recognition With Hearing EnhancementNot applicableCompleted6 Nov 2026Mirum Pharmaceuticals, Inc.United StatesExpanded-Access Program for the Treatment of Chronic Hepatitis D With BrelovitugAvailable6 Nov 2026Personalized Stem Cells, Inc.United StatesPilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain InjuryPhase 1Enrolling By Invitation6 Nov 2026Sun Pharma Advanced Research Company LimitedUnited StatesStudy of Electrocardiogram (ECG) Safety of Sezaby in Neonatal SeizuresPhase 4Not Yet Recruiting6 Nov 2026United TherapeuticsUnited StatesAn Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Phase 2, Phase 3Not Yet Recruiting6 Nov 2026United TherapeuticsUnited StatesStudy of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)Phase 2Not Yet Recruiting6 Nov 2026Viatris Inc.United StatesA Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic KeratopathyPhase 1, Phase 2Recruiting5 Nov 2026Amber Implants B.V.United StatesA Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.Recruiting5 Nov 2026Eli Lilly and CompanyUnited StatesA Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsPhase 1Not Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting5 Nov 2026PfizerUnited States, CanadaA Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Phase 3Recruiting5 Nov 2026Restore Biologics Holdings, Inc. dba XtresséUnited StatesStudy to Evaluate Xtressé Gummy Supplement in Women With Thinning HairNot applicableNot Yet Recruiting5 Nov 2026Somnum Pharma Inc.United StatesA Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic InsomniaPhase 2Not Yet Recruiting4 Nov 2026Arcutis Biotherapeutics, Inc.United StatesRoflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisPhase 3Recruiting4 Nov 2026Basilea PharmaceuticaUnited StatesA Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on DialysisPhase 1Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting4 Nov 2026Capstan MedicalUnited StatesEarly Feasibility Study of the Capstan Medical TMVR SystemNot applicableRecruiting4 Nov 2026Eli Lilly and CompanyUnited States, SingaporeA Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyPhase 1Recruiting4 Nov 2026GlaxoSmithKlineUnited States, United KingdomA Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Phase 2Recruiting4 Nov 2026Össur Iceland ehfUnited StatesHand Prosthesis Usability and PerformanceNot applicableRecruiting4 Nov 2026PfizerUnited StatesA Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Phase 3Recruiting3 Nov 2026Ensem TherapeuticsUnited StatesA KRAS Inhibitor in Participants With Advanced Solid TumorsPhase 1, Phase 2Recruiting3 Nov 2026Lambda Surgical, IncUnited StatesObservational Study of the LambdaGuide System for Measurement of Observable Genitourinary Anatomy During Cystoscopic Procedures in MenRecruiting3 Nov 2026Metagen Therapeutics, Inc.United States, JapanSafety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)Phase 1, Phase 2Recruiting3 Nov 2026Profil Institut für Stoffwechselforschung GmbHUnited StatesClinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp TechnologyNot Yet Recruiting3 Nov 2026Pulse Biosciences, Inc.United StatesTreating PHPT With the nPulse™ Vybrance™ PE SystemNot applicableNot Yet Recruiting// How AOS uses this